NCT00625456 2015-12-03Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsSillaJen, Inc.Phase 1 Completed23 enrolled
NCT00116597 2009-12-02Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic MelanomaUniversity Hospital, Basel, SwitzerlandPhase 1/2 Completed15 enrolled